About Contact Us Careers
Sign In

Bispecific Antibody Market - Top Companies and Manufacturers

  • Report ID: 5042
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Bispecific Antibody Market

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Innovent Biologics, Ltd.
    • Affimed GmbH
    • Pieris Pharmaceuticals, Inc.
    • Mereo BioPharma Group plc
    • TG Therapeutics, Inc.
    • MacroGenics, Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • AbbVie, Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • GlaxoSmithKline plc in a joint venture with Vir Biotechnology, Inc. announced the collaboration with the government of the United States. With this agreement, the companies will fulfill the need for 600,000 extra doses of Sotrovimab, it is a monoclonal antibody for the early treatment of COVID-19.
  • AbbVie Inc. announced the approval of the U.S. FDA for the world’s first and only T-cell-engaging bispecific antibody, EPKINLY. It is targeted for the treatment of persistent or refractory diffuse large B-cell lymphoma (DLBCL) in adults.

Author Credits:  Radhika Pawar


  • Report ID: 5042
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bispecific antibody is assessed at USD 609.64 million.

The bispecific antibody market size was valued at USD 576.44 million in 2024 and is set to reach USD 1.41 billion by the end of 2037, registering around 7.1% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of cancer, a higher instance of autoimmune diseases, and advancement in the bispecific antibody will boost the market growth.

North America industry is projected to hold 35% of the revenue share by 2037, due to rising demand for targeted and personalized therapies in the region.

The major players in the market include F. Hoffmann-La Roche Ltd., Innovent Biologics, Ltd., Affimed GmbH, Pieris Pharmaceuticals, Inc., Mereo BioPharma Group plc, TG Therapeutics, Inc., MacroGenics, Inc., Pfizer Inc., GlaxoSmithKline plc, AbbVie, Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample